Tegaserod-induced myocardial infarction: case report and hypothesis--an alternative viewpoint.
Pfannkuche
Hans-Juergen
HJ
Novartis Pharma AG, Basel, Switzerland.
Dennis
Eslie
E
D001291:Attitude of Health Personnel; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018589:Gastroparesis / Q000188:drug therapy*; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced*
D005765:Gastrointestinal Agents; D007211:Indoles; C105050:tegaserod